GERON CORP Logo

GERON CORP

A biopharma company developing a telomerase inhibitor for hematologic malignancies.

GERN | US

Overview

Corporate Details

ISIN(s):
US3741631036
LEI:
Country:
United States of America
Address:
919 EAST HILLSDALE BOULEVARD, 94404 FOSTER CITY

Description

Geron Corp is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for hematologic malignancies. Its lead product, imetelstat, is a first-in-class telomerase inhibitor approved for the treatment of certain blood cancers. The company's scientific approach targets telomerase to alter the course of hematologic myeloid malignancies, with the goal of extending and enhancing the lives of patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2017-05-09 18:02
10-Q
English ZIP 791.2 KB
2017-04-10 19:00
CURRENT REPORT
English ZIP 11.3 KB
2017-04-10 09:40
CURRENT REPORT
English ZIP 27.6 KB
2017-03-31 21:35
PRIMARY DOCUMENT
English ZIP 6.6 KB
2017-03-31 21:28
PRIMARY DOCUMENT
English ZIP 6.8 KB
2017-03-31 21:22
PRIMARY DOCUMENT
English ZIP 6.6 KB
2017-03-24 17:30
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
English ZIP 57.0 KB
2017-03-24 17:30
DEFINITIVE PROXY STATEMENT
English ZIP 301.7 KB
2017-03-03 08:30
CURRENT REPORT
English ZIP 55.1 KB
2017-03-01 17:10
CURRENT REPORT
English ZIP 34.2 KB
2017-03-01 16:57
10-K
English ZIP 1.7 MB
2017-02-14 12:20 English ZIP 10.1 KB
2017-02-10 21:15
PRIMARY DOCUMENT
English ZIP 6.9 KB
2017-02-10 21:07
PRIMARY DOCUMENT
English ZIP 6.9 KB
2017-02-10 21:00
PRIMARY DOCUMENT
English ZIP 6.9 KB

Automate Your Workflow. Get a real-time feed of all GERON CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GERON CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GERON CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
United Kingdom
ANAN
Designs, develops, and manufactures molecular diagnostic solutions and instruments.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Clinical-stage biopharmaceutical company developing therapeutics for CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and provides in-vitro diagnostic (IVD) solutions and instruments.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for acute cannabinoid intoxication.
United States of America
ANEB
AnGes, Inc. Logo
Biopharmaceutical firm developing gene-based and nucleotide-based medicines.
Japan
4563
Anika Therapeutics, Inc. Logo
A global joint preservation company developing solutions for orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops and commercializes veterinary pharmaceutical products and services globally.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded, generic, and OTC pharmaceutical products.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Clinical-stage biotech developing a cell-protecting biologic for RVO and oncology.
Sweden
ANNX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.